Soleno Therapeutics (SLNO)

• Market cap: $2.66B
• 1 day: -0.44%
• 5 days: 4.03%
• 1 month: -26.6%
• 3 months: -28.82%
• 6 months: -35.02%
• Year to date: 8.4%
• 1 year: -15.07%
• 5 years: 72.05%
• 10 years: -66.63%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Employees: 152